Otitis media and its consequences: beyond the earache
- PMID: 20185098
- DOI: 10.1016/S1473-3099(10)70012-8
Otitis media and its consequences: beyond the earache
Abstract
An international group of multidisciplinary experts on middle-ear and paediatric infections met to explore where consensus exists on the management of acute otitis media. After informal discussions among several specialists of paediatric infectious disease, the group was expanded to include a larger spectrum of professionals with complementary expertise in middle-ear disease. Acute otitis media is a very common bacterial infection in children worldwide, leading to excessive antibiotic consumption in children in most countries and to a substantial burden of deafness and suppurative complications in developing countries. The group attempted to move beyond the existing controversies surrounding guidelines on acute otitis media, and to propose to clinicians and public health officials their views on the actions needed to be taken to reduce the disease burden caused by acute otitis media and the microbial antibiotic resistance from the resulting use of antibiotics. Definition of acute otitis media and diagnostic accuracy are crucial steps to identify children who will potentially benefit from treatment with antibiotics and to eliminate unnecessary prescribing. Although the group agreed that antibiotics are distributed indiscriminately, even to children who do not seem to have the disease, no consensus could be reached on whether antibiotics should be given to all appropriately diagnosed children, reflecting the wide range of practices and lack of convincing evidence from observational studies. The major unanimous concern was an urgent need to reduce unnecessary prescribing of antibiotics to prevent further increases in antibiotic resistance. Prevention of acute otitis media with existing and future viral and bacterial vaccines seems the most promising approach to affect disease burden and consequences, both in developed and developing countries.
2010 Elsevier Ltd. All rights reserved.
Similar articles
-
Otitis media. A scholarly review of the evidence.Minerva Pediatr. 2003 Oct;55(5):407-14. Minerva Pediatr. 2003. PMID: 14608264 Review.
-
Pharmacotherapy of otitis media.Pharmacotherapy. 1991;11(3):212-21. Pharmacotherapy. 1991. PMID: 1862012 Review.
-
Otitis media in developing countries.Pediatrics. 1995 Jul;96(1 Pt 1):126-31. Pediatrics. 1995. PMID: 7596700 Review.
-
Antibiotic treatment for acute otitis media.Int J Pediatr Otorhinolaryngol. 2013 May;77(5):873-4. doi: 10.1016/j.ijporl.2013.03.006. Epub 2013 Mar 26. Int J Pediatr Otorhinolaryngol. 2013. PMID: 23537926
-
[Controversies in the treatment of acute otitis media].Przegl Lek. 2011;68(1):17-20. Przegl Lek. 2011. PMID: 21563438 Review. Polish.
Cited by
-
Panel 5: Microbiology and immunology panel.Otolaryngol Head Neck Surg. 2013 Apr;148(4 Suppl):E64-89. doi: 10.1177/0194599812459636. Otolaryngol Head Neck Surg. 2013. PMID: 23536533 Free PMC article. Review.
-
Bacterial and viral interactions within the nasopharynx contribute to the risk of acute otitis media.J Infect. 2013 Mar;66(3):247-54. doi: 10.1016/j.jinf.2012.12.002. Epub 2012 Dec 22. J Infect. 2013. PMID: 23266462 Free PMC article.
-
Examining the Evidence for an Adult Healthy Middle Ear Microbiome.mSphere. 2019 Sep 4;4(5):e00456-19. doi: 10.1128/mSphere.00456-19. mSphere. 2019. PMID: 31484741 Free PMC article.
-
Biofilm production by Haemophilus influenzae and Streptococcus pneumoniae isolated from the nasopharynx of children with acute otitis media.BMC Infect Dis. 2019 Jan 11;19(1):44. doi: 10.1186/s12879-018-3657-9. BMC Infect Dis. 2019. PMID: 30634919 Free PMC article.
-
Blocking macrophage migration inhibitory factor activity alleviates mouse acute otitis media in vivo.Immunol Lett. 2014 Nov;162(1 Pt A):101-8. doi: 10.1016/j.imlet.2014.07.013. Epub 2014 Aug 6. Immunol Lett. 2014. PMID: 25108100 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous